Small Intestine Cancer Research at City of Hope
November 22, 2024
This page was reviewed under our medical and editorial policy by Laleh Melstrom, M.D., M.S., associate professor of surgery and immuno-oncology, Division of Surgical Oncology, Department of Surgery, City of Hope® Cancer Center Duarte
Getting treated for small intestine cancer at City of Hope means you are steps away from labs where new treatments are being developed every day. That proximity means you will benefit from something unique in cancer care — “bench to bedside” treatment. Bench to bedside means exciting new research we are conducting in our labs is moved quickly to the bedside to treat our patients.
Small Intestine Cancer Research Projects
Some of our past and current research projects include:
- Performing a retrospective and prospective chart review of gastrointestinal cancers, including those in the small intestine, in adult patients
- Evaluating the safety, tolerability, pharmacokinetics and efficacy of AMG 193 in combination with other therapies in patients with gastrointestinal, biliary tract or pancreatic cancers with homozygous MTAP deletion
- Performing a prospective genetic and epigenetic analysis of gastrointestinal specimens from the small intestine, rectum and colon, in adult patients
Small Intestine Cancer Clinical Trials
Browse through some of City of Hope’s clinical trials and research projects.